CMPS Stock Summary and Trading Ideas (Compass Pathways PLC - American Depository Shares | NASDAQ:CMPS)

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Compass Pathways PLC - American Depository Shares trades on the NASDAQ stock market under the symbol CMPS.

As of October 5, 2026, CMPS stock price declined to $11.32 with 873,076 million shares trading.

CMPS has a beta of 2.37, meaning it tends to be more sensitive to market movements. CMPS has a correlation of 0.13 to the broad based SPY ETF.

CMPS has a market cap of $1.53 billion. This is considered a Small Cap stock.

In the last 3 years, CMPS traded as high as $15.87 and as low as $2.25.

The top ETF exchange traded funds that CMPS belongs to (by Net Assets): ARKG, IBB, PSIL, SBIO, GWX.

CMPS has outperformed the market in the last year with a return of +88.4%, while the SPY ETF gained +16.5%. However, in the most recent history, CMPS shares have underperformed the stock market with its stock returning -16.9% in the last 3 month period and -25.5% for the last 2 week period, while SPY has returned +3.9% and +1.4%, respectively.

CMPS support price is $11.42 and resistance is $12.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMPS shares will trade within this expected range on the day.